SPHK1 and pituitary tumor: The knockdown of SPHK1 suppresses S1P-mediated cell proliferation in GH3 cells by promoting autophagy and apoptosis with inhibition of GH secretion, which suggests that SIPR2 may be a promising therapeutic target for GH-secreting pituitary tumors.